Panacea Acquisition Corp. II

Panacea Acquisition Corp. II (Nasdaq: PANA) is a blank check company sponsored by Panacea Acquisition Corp. II Sponsor, LLC, an entity affiliated with Kevin Tang and Tang Capital Management, a firm with deep roots in healthcare investing. The SPAC completed its initial public offering in 2021 and focuses exclusively on the healthcare and life sciences sector, targeting businesses spanning biopharmaceuticals, medical devices, diagnostics, and health technology. The 10-Q filed on November 14, 2022, reflects the company's continued search for a qualifying acquisition target. As of that filing, PANA remained in its business combination phase. Sign up at SpacDesk for full data on PANA's filings, deal status, and comparable healthcare SPAC transactions.